Paget's disease and bisphosphonates.
Liel
Yair
Y
D000284:Administration, Oral; D019386:Alendronate / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000008:administration & dosage* / Q000191:economics; D004334:Drug Administration Schedule; D016527:Drug Costs; D012968:Etidronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000191:economics; D010001:Osteitis Deformans / Q000188:drug therapy*; D000068296:Risedronic Acid; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate